DRUG FACTS | Triadine Prep

12:44 EDT 24th July 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Povidone Iodine,10% w/v (equivalent to 1% titratable iodine)


For external use only.

If swallowed, get medical help or contact a Poison Control Center right away.

Cat. No. 10-8204NDC 50730-8204-4 TRIADINE™


For External Use Only! 4 Fluid Ounces (118 ml)

TRIAD GROUP, INC.700 West North Shore DriveHartland, WI 53029 MADE IN USA


Triad Group

Active Ingredients


Clinical Trials [149 Associated Clinical Trials listed on BioPortfolio]

Advanced HIV Prevention (PrEP Chicago)

This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their so...

PrEP for HBCUs (Study 2)

The investigators' overall goals are to target (a) pre-exposure prophylaxis (PrEP) uptake by addressing access and acceptability and (b) PrEP adherence among Historically Black Colleges an...

Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).

Pepped on PrEP is an innovative pilot RCT designed by an interdisciplinary team to develop a counseling and problem-solving PrEP adherence intervention with a Behavioral Activation (BA) ap...

PrEP Implementation for Mothers in Antenatal Care

In a region with 15-20% HIV prevalence, an estimated 20% of HIV-uninfected women could have HIV exposures in pregnancy. In a theoretical scenario of perfect PrEP coverage, all women at ris...

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

A safety study to compare the effect of two different formulations of PrEP-001 nasal powder when dosed in healthy subjects

PubMed Articles [99 Associated PubMed Articles listed on BioPortfolio]

An Experimental Investigation of Implicit Hiv And Prep Stigma: Evidence For Ancillary Benefits of Prep Use.

PrEP stigma (i.e., negative attitudes toward PrEP users) has been widely documented and is considered a significant barrier to implementation. However, few studies have examined PrEP stigma using impl...

Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP.

Oral preexposure prophylaxis (PrEP) has been proven to be a safe and effective means of preventing HIV. The purpose of our literature review was to examine primary care provider knowledge and attitude...

Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.

Gay, bisexual, and other men who have sex with men (GBM) are disproportionately affected by the HIV epidemic. Despite the promise of pre-exposure prophylaxis (PrEP) in reducing HIV transmission risk, ...

Body/Selves and Beyond: Men's Narratives of Sexual Behavior on PrEP.

Although pre-exposure prophylaxis (PrEP) has dramatically impacted HIV prevention, deep engagement with PrEP-takers' own accounts of their sexual behavior is still rare. We report findings from semi-s...

PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.

PrEP is efficacious for African women at risk for HIV, but data on adherence outside of clinical trials are sparse. We describe the persistence and execution of PrEP use among women participating in a...

Quick Search


Drugs and Medication Quicklinks

Searches Linking to this Drug Record